A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease (INCA 34176-254)
Researchers are leveraging the power of machine learning to support breast reconstruction decision-making among breast cancer patients. A breakthrough study, published in the journal Plastic and Reconstructive Surgery: Global Open, converts data on breast reconstruction outcomes following a mastectomy, which involves the removal of all or part of the breast, into a simple-to-use online tool to guide patient care discussions.
Walking into the Robotics and Control Laboratory (RCL), you first notice the rows of computers, many with researchers busily typing away in front of their screens. Beside desks and along the walls, robot arms and other apparatuses jut out at odd angles, some with wires cascading from them to racks of servers used to store dizzying amounts of data.
The Vancouver Coastal Health Research Institute (VCHRI) is pleased to welcome a new establishment to its growing roster of world-renowned research centres and programs. The M. H. Mohseni Institute of Urologic Sciences, a leading institute of its kind in Canada, launched in December 2024. Its establishment was made possible by over $65 million raised through a landmark campaign by the VGH & UBC Hospital Foundation.
Vancouver, BC — The M. H. Mohseni Institute of Urologic Sciences has officially launched within the Vancouver Coastal Health Research Institute, marking a significant advancement in the diagnosis, treatment and prevention of urologic diseases.
As 2024 comes to a close, we reflect with immense pride and gratitude on a remarkable year of research achievements. The Vancouver Coastal Health Research Institute (VCHRI) has welcomed new leadership and visionary strategies, further solidifying our standing as one of Canada’s leading research institutions.
Research Infosource Inc., a Canadian research, consulting and publishing firm, has released its annual ranking of Canada’s top 40 research hospitals. With $170 million in combined research funding for the 2023-2024 financial year, the Vancouver Coastal Health Research Institute (VCHRI) and Providence Research have once again ranked among the top hospital-based research institutes nationwide.
Master Protocol of Two Independent, Randomized, Double-blind Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis
New Vancouver Coastal Health Research Institute (VCHRI)-led research reveals an alarming number of people suffering spinal cord injuries while mountain biking, often leading to permanent and life-altering paralysis.
With more than 18 per cent of people aged 65 and older, Canada’s aging population is in need of innovative, research-based approaches to slow brain decline and better the quality of life of older adults.
